CURRENT COMPUTER-AIDED DRUG DESIGN, cilt.16, sa.2, ss.104-121, 2020 (SCI-Expanded)
Background: Sulpiride, which has selective dopaminergic blocking activity, is a substituted benzamide antipsychotic drug playing a prominent role in the treatment of schizophrenia, which more selective and primarily blocks dopamine D2 and D3 receptor.